For research use only. Not for therapeutic Use.
GW438014A（Cat No.:I011000）is an investigational compound primarily studied for its potential in treating autoimmune and inflammatory diseases. It functions as a selective inhibitor targeting specific receptors involved in immune cell activation and cytokine production. By modulating these pathways, GW438014A aims to reduce excessive immune responses and inflammation, which are central to conditions such as rheumatoid arthritis and inflammatory bowel disease. Early studies show promising results in controlling inflammation and improving clinical outcomes. Further clinical trials are underway to assess its safety, efficacy, and long-term therapeutic potential in managing immune-related disorders.
| CAS Number | 469861-49-2 |
| Synonyms | methanesulfonic acid;N-[1-(2-phenylethyl)benzimidazol-2-yl]benzamide |
| Molecular Formula | C23H23N3O4S |
| Purity | ≥95% |
| IUPAC Name | methanesulfonic acid;N-[1-(2-phenylethyl)benzimidazol-2-yl]benzamide |
| InChI | InChI=1S/C22H19N3O.CH4O3S/c26-21(18-11-5-2-6-12-18)24-22-23-19-13-7-8-14-20(19)25(22)16-15-17-9-3-1-4-10-17;1-5(2,3)4/h1-14H,15-16H2,(H,23,24,26);1H3,(H,2,3,4) |
| InChIKey | AVYFZOKRFCFQLP-UHFFFAOYSA-N |
| SMILES | CS(=O)(=O)O.C1=CC=C(C=C1)CCN2C3=CC=CC=C3N=C2NC(=O)C4=CC=CC=C4 |
